Correction to: How do patients define Raynaud’s phenomenon? Differences between primary and secondary disease (Clinical Rheumatology, (2021), 40, 4, (1611-1616), 10.1007/s10067-021-05598-7)

Susan L Murphy; Alain Lescoat; Mary Alore; Michael Hughes; John D Pauling; Maya Sabbagh; Dinesh Khanna

doi:10.1007/s10067-021-05620-y

Correction to: How do patients define Raynaud’s phenomenon? Differences between primary and secondary disease (Clinical Rheumatology, (2021), 40, 4, (1611-1616), 10.1007/s10067-021-05598-7)

Susan L Murphy, Alain Lescoat, Mary Alore, Michael Hughes, John D Pauling, Maya Sabbagh, Dinesh Khanna

Department of Life Sciences

Research output: Contribution to journal › Comment/debate › peer-review

2 Citations (SciVal)

Abstract

In the original published version of the above article, the tables were not presented; thus, the tables are now available in the original article. The original article has been corrected.

Original language	English
Pages (from-to)	1617-1620
Number of pages	4
Journal	Clinical Rheumatology
Volume	40
Issue number	4
Early online date	6 Feb 2021
DOIs	https://doi.org/10.1007/s10067-021-05620-y
Publication status	Published - 30 Apr 2021

Access to Document

10.1007/s10067-021-05620-y

Cite this

Murphy, S. L., Lescoat, A., Alore, M., Hughes, M., Pauling, J. D., Sabbagh, M., & Khanna, D. (2021). Correction to: How do patients define Raynaud’s phenomenon? Differences between primary and secondary disease (Clinical Rheumatology, (2021), 40, 4, (1611-1616), 10.1007/s10067-021-05598-7). Clinical Rheumatology, 40(4), 1617-1620. https://doi.org/10.1007/s10067-021-05620-y

Correction to: How do patients define Raynaud’s phenomenon? Differences between primary and secondary disease (Clinical Rheumatology, (2021), 40, 4, (1611-1616), 10.1007/s10067-021-05598-7). / Murphy, Susan L; Lescoat, Alain; Alore, Mary et al.
In: Clinical Rheumatology, Vol. 40, No. 4, 30.04.2021, p. 1617-1620.

Research output: Contribution to journal › Comment/debate › peer-review

Murphy, SL, Lescoat, A, Alore, M, Hughes, M, Pauling, JD, Sabbagh, M & Khanna, D 2021, 'Correction to: How do patients define Raynaud’s phenomenon? Differences between primary and secondary disease (Clinical Rheumatology, (2021), 40, 4, (1611-1616), 10.1007/s10067-021-05598-7)', Clinical Rheumatology, vol. 40, no. 4, pp. 1617-1620. https://doi.org/10.1007/s10067-021-05620-y

@article{7446e8a794fd4b6ca2c9ea9302b44bca,

title = "Correction to: How do patients define Raynaud{\textquoteright}s phenomenon? Differences between primary and secondary disease (Clinical Rheumatology, (2021), 40, 4, (1611-1616), 10.1007/s10067-021-05598-7)",

abstract = "In the original published version of the above article, the tables were not presented; thus, the tables are now available in the original article. The original article has been corrected.",

author = "Murphy, {Susan L} and Alain Lescoat and Mary Alore and Michael Hughes and Pauling, {John D} and Maya Sabbagh and Dinesh Khanna",

year = "2021",

month = apr,

day = "30",

doi = "10.1007/s10067-021-05620-y",

language = "English",

volume = "40",

pages = "1617--1620",

journal = "Clinical Rheumatology",

issn = "1434-9949",

publisher = "Springer London",

number = "4",

}

TY - JOUR

T1 - Correction to

T2 - How do patients define Raynaud’s phenomenon? Differences between primary and secondary disease (Clinical Rheumatology, (2021), 40, 4, (1611-1616), 10.1007/s10067-021-05598-7)

AU - Murphy, Susan L

AU - Lescoat, Alain

AU - Alore, Mary

AU - Hughes, Michael

AU - Pauling, John D

AU - Sabbagh, Maya

AU - Khanna, Dinesh

PY - 2021/4/30

Y1 - 2021/4/30

N2 - In the original published version of the above article, the tables were not presented; thus, the tables are now available in the original article. The original article has been corrected.

AB - In the original published version of the above article, the tables were not presented; thus, the tables are now available in the original article. The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85100470684&partnerID=8YFLogxK

U2 - 10.1007/s10067-021-05620-y

DO - 10.1007/s10067-021-05620-y

M3 - Comment/debate

C2 - 33547561

SN - 1434-9949

VL - 40

SP - 1617

EP - 1620

JO - Clinical Rheumatology

JF - Clinical Rheumatology

IS - 4

ER -

Correction to: How do patients define Raynaud’s phenomenon? Differences between primary and secondary disease (Clinical Rheumatology, (2021), 40, 4, (1611-1616), 10.1007/s10067-021-05598-7)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this